DK543787A - Naphthyridin-, quinolin- og benzoxazincarboxylsyreforbindelser med antibakteriel aktivitet - Google Patents
Naphthyridin-, quinolin- og benzoxazincarboxylsyreforbindelser med antibakteriel aktivitetInfo
- Publication number
- DK543787A DK543787A DK543787A DK543787A DK543787A DK 543787 A DK543787 A DK 543787A DK 543787 A DK543787 A DK 543787A DK 543787 A DK543787 A DK 543787A DK 543787 A DK543787 A DK 543787A
- Authority
- DK
- Denmark
- Prior art keywords
- quinoline
- naphthyridine
- carboxylic acid
- acid compounds
- antibacterial activity
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 2
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 title 1
- ZMDQWHCTODNNLT-UHFFFAOYSA-N 2h-1,2-benzoxazine-3-carboxylic acid Chemical class C1=CC=C2ONC(C(=O)O)=CC2=C1 ZMDQWHCTODNNLT-UHFFFAOYSA-N 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- CSAYVSRENVQAPV-UHFFFAOYSA-N N1=CC=CC2=CC=CC=C21.C1=CC=C2ONC(C(=O)O)=CC2=C1 Chemical class N1=CC=CC2=CC=CC=C21.C1=CC=C2ONC(C(=O)O)=CC2=C1 CSAYVSRENVQAPV-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/920,536 US4822801A (en) | 1984-07-20 | 1986-10-20 | 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK543787D0 DK543787D0 (da) | 1987-10-16 |
| DK543787A true DK543787A (da) | 1988-04-21 |
Family
ID=25443916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK543787A DK543787A (da) | 1986-10-20 | 1987-10-16 | Naphthyridin-, quinolin- og benzoxazincarboxylsyreforbindelser med antibakteriel aktivitet |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4822801A (enExample) |
| EP (1) | EP0265230B1 (enExample) |
| JP (2) | JP2750117B2 (enExample) |
| KR (1) | KR880005137A (enExample) |
| AT (1) | ATE71375T1 (enExample) |
| AU (1) | AU643489B2 (enExample) |
| CA (1) | CA1336089C (enExample) |
| DE (1) | DE3775882D1 (enExample) |
| DK (1) | DK543787A (enExample) |
| ES (1) | ES2040261T3 (enExample) |
| FI (1) | FI874570A7 (enExample) |
| GR (1) | GR3003548T3 (enExample) |
| IE (1) | IE64492B1 (enExample) |
| NO (1) | NO874350L (enExample) |
| PH (3) | PH24199A (enExample) |
| PT (1) | PT85943B (enExample) |
| ZA (1) | ZA877887B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH089597B2 (ja) * | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| US5173484A (en) * | 1988-02-05 | 1992-12-22 | Bayer Aktiengesellschaft | Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them |
| JPH0228178A (ja) * | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法 |
| KR910003630B1 (ko) * | 1988-06-17 | 1991-06-07 | 한국과학기술원 | 벤조일 아세틱 에스테르 유도체 및 그 제조방법 |
| JPH0674261B2 (ja) * | 1988-06-21 | 1994-09-21 | 塩野義製薬株式会社 | キノロンカルボン酸誘導体 |
| AU618823B2 (en) * | 1988-07-20 | 1992-01-09 | Sankyo Company Limited | 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use |
| ES2147721T3 (es) | 1990-04-18 | 2000-10-01 | Procter & Gamble Pharma | Quinolonil lactamas antimicrobianas. |
| CA2128601C (en) * | 1992-01-31 | 2003-07-15 | Hiroyuki Nagano | Quinolone carboxylic acid derivatives in crystalline hydrate form |
| US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| KR970704693A (ko) * | 1994-07-18 | 1997-09-06 | 나가히로 마오미 | 트리플루오로메틸퀴놀린카르복실산 유도체(trifluoromethylquinolinecarboxylic acid derivative) |
| US5602254A (en) * | 1995-05-26 | 1997-02-11 | Warner-Lambert Company | Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form |
| DE19652239A1 (de) | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| US6387928B1 (en) | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
| SK286420B6 (sk) | 1997-09-15 | 2008-09-05 | The Procter & Gamble Company | Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie |
| US7098219B2 (en) | 2000-08-01 | 2006-08-29 | Wockhart Limited | Inhibitors of cellular efflux pumps of microbes |
| US6878713B2 (en) | 2001-04-25 | 2005-04-12 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US6964966B2 (en) | 2001-04-25 | 2005-11-15 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| KR20040094806A (ko) * | 2002-03-18 | 2004-11-10 | 교린 세이야꾸 가부시키 가이샤 | 내성균에 유효한10-(3-시클로프로필아미노메틸-1-피로리디닐)피리도벤즈옥사진 카르본산 유도체 |
| US6664267B1 (en) | 2002-05-28 | 2003-12-16 | Wockhardt Limited | Crystalline fluoroquinolone arginine salt form |
| JP5255183B2 (ja) | 2003-09-04 | 2013-08-07 | ウォックハート リミテッド | ベンゾキノリジン−２−カルボン酸アルギニン塩四水和物 |
| WO2005026147A1 (ja) | 2003-09-10 | 2005-03-24 | Kyorin Pharmaceutical Co., Ltd. | ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体 |
| WO2005111030A1 (en) * | 2004-05-12 | 2005-11-24 | Warner-Lambert Company Llc | Quinolone antibacterial agents |
| US20090156577A1 (en) * | 2004-09-09 | 2009-06-18 | Benjamin Davis | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| US7563805B2 (en) | 2005-05-19 | 2009-07-21 | Daiichi Pharmaceutical Co., Ltd. | Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| CA2645376C (en) | 2006-03-13 | 2017-06-20 | Activx Biosciences, Inc. | Aminoquinolones as gsk-3 inhibitors |
| MX2008012488A (es) * | 2006-03-28 | 2008-10-10 | Procter & Gamble | Un proceso de acoplamiento para preparar intermedios de quinolona. |
| EP2001862B1 (en) * | 2006-03-28 | 2011-04-27 | Warner Chilcott Company, LLC | Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid |
| CA2647457C (en) * | 2006-03-28 | 2011-05-24 | The Procter & Gamble Company | A hydride reduction process for preparing quinolone intermediates |
| JP5322927B2 (ja) * | 2007-05-24 | 2013-10-23 | 杏林製薬株式会社 | １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体 |
| US7902227B2 (en) * | 2007-07-27 | 2011-03-08 | Janssen Pharmaceutica Nv. | C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents |
| CN102351880B (zh) | 2007-09-11 | 2014-11-12 | 杏林制药株式会社 | 作为gsk-3 抑制剂的氰基氨基喹诺酮和四唑并氨基喹诺酮 |
| US8476261B2 (en) | 2007-09-12 | 2013-07-02 | Kyorin Pharmaceutical Co., Ltd. | Spirocyclic aminoquinolones as GSK-3 inhibitors |
| EP2222662A4 (en) * | 2007-11-15 | 2011-08-03 | Univ Maryland | INHIBITORS OF KYNURENINE AMINO TRANSFERASE |
| MX2011009414A (es) * | 2009-03-11 | 2011-10-19 | Kyorin Seiyaku Kk | 7-cicloalquiloaminoquinolonas como inhibidores de gsk-3. |
| US9573902B2 (en) * | 2013-02-15 | 2017-02-21 | Laurus Labs Private Ltd. | Process for the preparation of Ivacaftor and its intermediates |
| KR102213991B1 (ko) * | 2014-05-20 | 2021-02-09 | 동화약품주식회사 | 개선된 자보플록사신의 제조방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049811A (en) * | 1968-07-23 | 1977-09-20 | Boehringer Mannheim G.M.B.H. | Compositions using cycloalkano-quinolone derivatives and their method of use |
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| US4665079A (en) * | 1984-02-17 | 1987-05-12 | Warner-Lambert Company | Antibacterial agents |
| US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
| US4604401A (en) * | 1984-07-20 | 1986-08-05 | Warner-Lambert Company | Antibacterial agents III |
| IE58742B1 (en) * | 1984-07-20 | 1993-11-05 | Warner Lambert Co | Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds |
| AU576272B2 (en) * | 1984-11-13 | 1988-08-18 | Kyorin Pharmaceutical Co. Ltd. | Quinolone carboxylic acid derivates |
| AU578793B2 (en) * | 1985-02-15 | 1988-11-03 | Dainippon Pharmaceutical Co. Ltd. | Novel 1,8-naphthyridine derivatives and processes for preparation thereof |
| JPH089597B2 (ja) * | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| JPH0720940B2 (ja) * | 1986-02-28 | 1995-03-08 | 大日本製薬株式会社 | キノリン誘導体の製造法 |
| US4780408A (en) * | 1986-03-26 | 1988-10-25 | Colorado State University Research Foundation | Antibody for detection and quantification of trifluralin |
| JPH0720941B2 (ja) * | 1986-03-28 | 1995-03-08 | 大日本製薬株式会社 | 新規キノロン誘導体、そのエステルおよびその塩 |
| EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
| US4771055A (en) * | 1986-07-28 | 1988-09-13 | Warner-Lambert Company | 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids |
| JPS63152318A (ja) * | 1986-08-07 | 1988-06-24 | Dainippon Pharmaceut Co Ltd | 抗マイコプラズマ剤 |
-
1986
- 1986-10-20 US US06/920,536 patent/US4822801A/en not_active Expired - Lifetime
-
1987
- 1987-09-18 CA CA000547233A patent/CA1336089C/en not_active Expired - Fee Related
- 1987-09-25 IE IE259087A patent/IE64492B1/en not_active IP Right Cessation
- 1987-10-16 FI FI874570A patent/FI874570A7/fi not_active Application Discontinuation
- 1987-10-16 DK DK543787A patent/DK543787A/da not_active Application Discontinuation
- 1987-10-19 PT PT85943A patent/PT85943B/pt not_active IP Right Cessation
- 1987-10-19 NO NO874350A patent/NO874350L/no unknown
- 1987-10-19 JP JP62261929A patent/JP2750117B2/ja not_active Expired - Fee Related
- 1987-10-20 KR KR870011656A patent/KR880005137A/ko not_active Ceased
- 1987-10-20 PH PH35962A patent/PH24199A/en unknown
- 1987-10-20 DE DE8787309267T patent/DE3775882D1/de not_active Expired - Fee Related
- 1987-10-20 ES ES198787309267T patent/ES2040261T3/es not_active Expired - Lifetime
- 1987-10-20 ZA ZA877887A patent/ZA877887B/xx unknown
- 1987-10-20 EP EP87309267A patent/EP0265230B1/en not_active Expired - Lifetime
- 1987-10-20 AT AT87309267T patent/ATE71375T1/de not_active IP Right Cessation
-
1989
- 1989-04-03 PH PH38420A patent/PH25459A/en unknown
- 1989-04-03 PH PH38421A patent/PH25423A/en unknown
-
1991
- 1991-01-07 AU AU69205/91A patent/AU643489B2/en not_active Ceased
-
1992
- 1992-01-09 GR GR910402252T patent/GR3003548T3/el unknown
-
1997
- 1997-10-08 JP JP27539997A patent/JP3235539B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU643489B2 (en) | 1993-11-18 |
| NO874350L (no) | 1988-04-21 |
| JPH10114779A (ja) | 1998-05-06 |
| AU7987987A (en) | 1988-04-21 |
| NO874350D0 (no) | 1987-10-19 |
| PH25459A (en) | 1991-07-01 |
| ES2040261T3 (es) | 1993-10-16 |
| EP0265230A1 (en) | 1988-04-27 |
| FI874570A7 (fi) | 1988-04-21 |
| AU6920591A (en) | 1991-03-28 |
| GR3003548T3 (enExample) | 1993-03-16 |
| PT85943B (pt) | 1990-07-31 |
| DK543787D0 (da) | 1987-10-16 |
| JP2750117B2 (ja) | 1998-05-13 |
| DE3775882D1 (de) | 1992-02-20 |
| ATE71375T1 (de) | 1992-01-15 |
| IE872590L (en) | 1988-04-20 |
| EP0265230B1 (en) | 1992-01-08 |
| PT85943A (en) | 1987-11-01 |
| JPS63104974A (ja) | 1988-05-10 |
| FI874570A0 (fi) | 1987-10-16 |
| KR880005137A (ko) | 1988-06-28 |
| PH24199A (en) | 1990-04-10 |
| ZA877887B (en) | 1989-05-30 |
| IE64492B1 (en) | 1995-08-09 |
| AU606618B2 (en) | 1991-02-14 |
| US4822801A (en) | 1989-04-18 |
| JP3235539B2 (ja) | 2001-12-04 |
| PH25423A (en) | 1991-07-01 |
| CA1336089C (en) | 1995-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK543787A (da) | Naphthyridin-, quinolin- og benzoxazincarboxylsyreforbindelser med antibakteriel aktivitet | |
| NO180719C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive A-nor-steroid-3-carboxylsyrederivater | |
| FR2692264B1 (fr) | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. | |
| DK390587A (da) | 7-oeoe3-aminomethyl-3-alkylaa-1-pyrrolidinylaa-quino lin-carboxylsyre | |
| NO173445C (no) | Analogifremgansmaate for fremstilling av terapeutisk aktive kinolinkarboksylyrederivater | |
| NO177934C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kinolinkarboksylsyrederivater | |
| GR3021014T3 (en) | 2-Substituted quinolines, process for their preparation as well as their use in medicaments | |
| PT81476A (en) | Process for the preparation of quinolone carboxylic acid derivatives | |
| NO901171D0 (no) | Fremgangsmaate til fremstilling av substituerte azetidinylpyridonkarboksylsyrederivater. | |
| PL235576A1 (en) | Process for preparing derivatives of penicillanic acid | |
| ATE48836T1 (de) | Verfahren zur herstellung von antibakteriellen chinolin-3-carbonsaeure-werkstoffen. | |
| IT1229846B (it) | Esteri di catecolammine. | |
| DE3777724D1 (de) | 2-amino-3-aroyl-gamma-oxobenzolbuttersaeure und ihre ester. | |
| PT87064A (pt) | Process for the preparation of 5-hydroxydiprafenone and its acid addition salts | |
| FI882667A7 (fi) | Foerfarande foer framstaellning av antibakteriska vid 7-staellningen substituerade 1-cyklopropyl-6-fluor -1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyror. | |
| ATE132865T1 (de) | 3-anilino-2-hydroxycarbonyl-4-thiophenessigsäur n |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |